| |
 |
 |
 |
 |
 |
 |
 |
February 20, 2003
Personnel
Changes at AnGes MG
(Departure
of a Representative Director/Appointment of a new Director)
|
 |
|
|
AnGes MG Inc. has announced the tentative decision
at the Board of Directors meeting convened February 20, 2003
to make the following personnel changes:
1.Departure
of a Representative Director
(1)Personnel
change (resignation) detail
Name
(Date of birth) |
Effective
date |
Position
title |
| Pre-change |
Post-change |
Masanori MURAYAMA
( July 7, 1960) |
February 28, 2003
(resignation from post) |
Representative
Director & CFO |
----------- |
|
(2)Reason of
resignation
As President/CEO of AnGes MG from April 2001 to September 2002,
Masanori MURAYAMA strived to strengthen the company's management
structures, chiefly utilizing his excellent expertise in finance,
and achieving some remarkable accomplishments epitomized by
the company's IPO on September 25, 2002. Now, he has tendered
his resignation for personal reasons, after having accomplished
the key goals on his agenda.
AnGes MG decided to grant his resignation at the board of directors
meeting, after verifying that its post-IPO corporate operations
under the leadership of President/CEO Ei YAMADA (since his appointment
on September 3, 2002), have remained stable.
2.Appointment
of new Director
(1)Name
and career of the new director
| Title |
Name
(Date of birth) |
Background |
Director
(External) |
Shiro
ENOKI
(October 3, 1937) |
-June 1998:
Appointed President of
SEIKAGAKU CORPORATION (present post)
-June 1996: Appointed Executive
Managing Director of SEIKAGAKU CORPORATION
-June 1994: Appointed Planning Manager,
Director of SEIKAGAKU CORPORATION
-April 1994: Appointed Planning Manager
of SEIKAGAKU CORPORATION
-March 1994: Joined SEIKAGAKU CORPORATION
(Executive Board Member)
-June 1991 : Monsanto Kasei Co., Ltd. (Director
&
Admin Manager)
-April 1960: Joined Mitsubishi Kasei Corporation
(present Mitsubishi Chemical Corporation) |
|
(2)Appointment
effective as of: March 27, 2003
(Subject to approval by the company's General Shareholders'
Meeting to be convened on March 27, 2003)
(3)Reasons
for appointment of external director
AnGes MG, as a biochemical venture company, has been striving
to optimize its management structures, and has been accordingly
setting its sight on transforming its organizational structure.
The company was fully aware that only a well-versed veteran
from the industry who can reconcile the importance of corporate
governance with the need for corporate transparency can adequately
meet the requirements of accountability towards investors or
stockholders.
Shiro ENOKI is an executive officer of SEIKAGAKU CORPORATION
(which had its IPO 13 years ago) a leading pharmaceutical company
established over half a century ago. AnGes MG has decided to
invite him as an external director, in order to reinforce its
corporate governance to better ensure legal compliance of its
corporate management practices, and to maximize stockholder
benefits and profits, through Mr. ENOKI's objective and multifaceted
business perspective, backed by his extensive experience. |
|
|
